MedTrace Logo

Hyperbaric Prilocaine 2% vs Hyperbaric Bupivacaine 0.5% in Caesarean Section

NCT06680167 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2026-03-30

No results posted yet for this study

Summary

Comparison between effects of hyperbaric bupivacaine 0.5% vs Hyperbaric prilocaine 2% in spinal anesthesia of women undergoing elective caesarean section such as onset time of sensory and motor block, duration of sensory and motor block, effects of maternal hemodynamics and expected side effects .

Conditions

  • Spinal Anesthesia

Interventions

DRUG

Spinal anesthesia (heavy bupivacaine 0.5%)

12.5mg of Heavy bupivacaine 0.5% will be injected intrathecally for women undergoing elective caesarean section

DRUG

spinal anesthesia (hyperbaric Prilocaine 2%)

60mg of Hyperbaric Prilocaine 2% will be injected intrathecally for women undergoing elective caesarean section

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-09
Primary Completion
2025-11-05
Completion
2025-12-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06680167 on ClinicalTrials.gov